Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin filaments in the stratum corneum are the primary structural components of the skin's outermost layer, providing a tough, insoluble barrier against environmental insults and water loss (StatPearls, NBK560714). These intermediate filaments, primarily composed of Keratin 1 and Keratin 10 in the suprabasal layers, undergo extensive cross-linking with proteins like loricrin and filaggrin to form the cornified envelope (UniProt, P04264). In various dermatological conditions such as psoriasis and ichthyosis, there is an overproduction or abnormal organization of these filaments, leading to hyperkeratosis and impaired barrier function (PubMed, 17503915). Therapeutic interventions often involve keratolytic agents like salicylic acid or urea, which soften and facilitate the shedding of the stratum corneum by disrupting the hydrogen bonds and protein structures within the keratin matrix. Additionally, retinoids modulate the expression of keratin genes to normalize skin cell turnover and differentiation. Understanding the dynamics of these filaments is crucial for developing treatments for skin disorders characterized by scaling and thickening of the epidermis.
Keratolytic agents act by disrupting the cohesive forces between keratinocytes and the structural integrity of keratin filaments through the breaking of hydrogen bonds and protein denaturation, thereby promoting desquamation. Retinoids and vitamin D analogs modulate the expression of keratin genes (e.g., KRT1 and KRT10) to normalize epidermal differentiation and reduce hyperkeratosis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin filament (Stratum corneum) (KRT).